Multicenter Phase 1b/2a Clinical Trial of Radioprotectant BIO 300 Oral Suspension for Patients with Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy (vol 118, pg 404, 2023)

被引：0
|
作者：
Simone II, C. B.
Serebrenik, A. A.
Gore, E. M.
机构：
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 119卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2024.02.009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1029 / 1029
页数：1
相关论文
共 50 条
  • [31] Ceritinib plus Nivolumab in Patients with Advanced ALK-Rearranged Non-Small Cell Lung Cancer: Results of an Open-Label, Multicenter, Phase 1B Study
    Felip, Enriqueta
    de Braud, Filippo G.
    Maur, Michela
    Loong, Herbert H.
    Shaw, Alice Tsang
    Vansteenkiste, Johan F.
    John, Thomas
    Liu, Geoffrey
    Lolkema, Martijn P.
    Selvaggi, Giovanni
    Giannone, Vanessa
    Cazorla, Pilar
    Baum, Jason
    Balbin, O. Alejandro
    Wang, Luojun
    Lau, Yvonne Y.
    Scott, Jeffrey W.
    Tan, Daniel Shao-Weng
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (03) : 392 - 403
  • [32] Phase 1b Study of Motesanib, an Oral Angiogenesis Inhibitor, in Combination with Carboplatin/Paclitaxel and/or Panitumumab for the Treatment of Advanced Non-Small Cell Lung Cancer
    Blumenschein, George R., Jr.
    Reckamp, Karen
    Stephenson, G. Joe
    O'Rourke, Timothy
    Gladish, Gregory
    McGreivy, Jesse
    Sun, Yu-Nien
    Ye, Yining
    Parson, Mandy
    Sandler, Alan
    CLINICAL CANCER RESEARCH, 2010, 16 (01) : 279 - 290
  • [33] Phase 1/2 study of the safety and clinical activity of durvalumab in patients with non-small cell lung cancer (NSCLC)
    Antonia, S. J.
    Brahmer, J. R.
    Khleif, S.
    Balmanoukian, A. S.
    Ou, S-H. I.
    Gutierrez, M.
    Kim, D-W.
    Kim, S-W.
    Ahn, M-J.
    Leach, J.
    Jamal, R.
    Jaeger, D.
    Jerusalem, G.
    Jin, X.
    Gupta, A.
    Antal, J.
    Segal, N. H.
    ANNALS OF ONCOLOGY, 2016, 27
  • [34] A Phase I Trial of the HIV Protease Inhibitor Nelfinavir with Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer A Report of Toxicities and Clinical Response
    Rengan, Ramesh
    Mick, Rosemarie
    Pryma, Daniel
    Rosen, Mark A.
    Lin, Lilie L.
    Maity, Amit M.
    Evans, Tracey L.
    Stevenson, James P.
    Langer, Corey J.
    Kucharczuk, John
    Friedberg, Joseph
    Prendergast, Susan
    Sharkoski, Tiffany
    Hahn, Stephen M.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (04) : 709 - 715
  • [35] A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer
    Liao, ZX
    Komaki, R
    Milas, L
    Yuan, C
    Kies, M
    Chang, JY
    Jeter, M
    Guerrero, T
    Blumenschien, G
    Smith, CM
    Fossella, F
    Brown, B
    Cox, JD
    CLINICAL CANCER RESEARCH, 2005, 11 (09) : 3342 - 3348
  • [36] Addition of Metformin to Concurrent Chemoradiation in Patients With Locally Advanced Non-Small Cell Lung Cancer The NRG-LU001 Phase 2 Randomized Clinical Trial
    Skinner, Heath
    Hu, Chen
    Tsakiridis, Theodoros
    Santana-Davila, Rafael
    Lu, Bo
    Erasmus, Jeremy J.
    Doemer, Anthony J.
    Videtic, Gregory M. M.
    Coster, James
    Yang, Alex Xuezhong
    Lee, Richard Y.
    Werner-Wasik, Maria
    Schaner, Philip E.
    McCormack, Steven E.
    Esparaz, Benjamin T.
    McGarry, Ronald C.
    Bazan, Jose
    Struve, Timothy
    Paulus, Rebecca
    Bradley, Jeffrey D.
    JAMA ONCOLOGY, 2021, 7 (09) : 1324 - 1332
  • [37] A Phase 1b Study of Demcizumab Plus Pemetrexed and Carboplatin in Patients with 1st Line Non-Small Cell Lung Cancer (NSCLC)
    McKeage, M.
    Kotasek, D.
    Millward, M.
    Markman, B.
    Jameson, M.
    Hidalgo, M.
    Harris, D.
    Stagg, R.
    Dupont, J.
    Hughes, B.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 183 - 184
  • [38] A phase 1b study evaluating the safety and preliminary efficacy of berzosertib in combination with gemcitabine in patients with advanced non-small cell lung cancer
    Plummer, Ruth
    Dean, Emma
    Arkenau, Hendrik-Tobias
    Redfern, Charles
    Spira, Alexander I. I.
    Melear, Jason M. M.
    Chung, Ki Y. Y.
    Ferrer-Playan, Jordi
    Goddemeier, Thomas
    Locatelli, Giuseppe
    Dong, Jennifer
    Fleuranceau-Morel, Patricia
    Diaz-Padilla, Ivan
    Shapiro, Geoffrey I. I.
    LUNG CANCER, 2022, 163 : 19 - 26
  • [39] ENCORE-601: Phase 1b/2 study of entinostat (ENT) in combination with pembrolizumab (PEMBRO) in patients with non-small cell lung cancer (NSCLC)
    Gandhi, Leena
    Johnson, Melissa L.
    Opyrchal, Mateusz
    Ramalingam, Suresh
    Janne, Pasi
    Chachoua, Abraham
    Ordentlich, Peter
    Brouwer, Susan
    Sankoh, Serap
    Schmidt, Emmett
    Meyers, Michael L.
    Hellmann, Matthew
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [40] A phase 1b study of cofetuzumab pelidotin monotherapy in patients with PTK7-expressing recurrent non-small cell lung cancer
    Cho, Byoung Chul
    Johnson, Melissa
    Bar, Jair
    Schaefer, Eric
    Yoh, Kiyotaka
    Zer, Alona
    Moskovitz, Mor
    Lee, Se-Hoon
    Moreno, Victor
    de Miguel, Maria
    Okuma, Yusuke
    Kim, Joo-Hang
    Lee, Chun-Hui
    Peguero, Julio
    Ansell, Peter
    Biesdorf, Carla
    Saab, Rabih
    Freise, Kevin J.
    Ramies, David
    Jeng, Edwin E.
    Camidge, D. Ross
    LUNG CANCER, 2025, 202
12345